Found 19 matching trials
Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer PHASE2 Background:
\- Enzalutamide is a well tolerated hormone therapy that is us...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer PHASE1 This study study aims to elucidate the immune responses to a shared antigen...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer PHASE2 Background:
* Flutamide is an approved drug for prostate cancer that block...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Sequential Vaccinations in Prostate Cancer Patients PHASE1 Background:
" Adenocarcinoma of the prostate is the most common cancer dia...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer PHASE2 This study is a prospective, open label, single arm phase II trial. A total...
Show More Location
Huntsman Cancer Institute
Learn More & Join Trial
A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer PHASE2 Vaccines made from a gene-modified virus may help the body build an effecti...
Show More Location
Baptist Cancer Institute
Learn More & Join Trial
PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer PHASE1 Background:
The immune system is the cells and organs in the body that rec...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer PHASE2 Background:
Metastatic castrate-sensitive prostate cancer is cancer that h...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy PHASE2 The purpose of this study is to see how well PROSTVAC -V/F works in stoppin...
Show More Location
Medical University of South Carolina
Learn More & Join Trial
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer PHASE3 The purpose of this study is to determine whether PROSTVAC alone or in comb...
Show More Location
Alaska Clinical Research Center, Llc
Learn More & Join Trial